Clinical Trial Update: Nicotinamide Mononucleotide in Hypertensive Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update for nicotinamide mononucleotide in hypertensive patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Nicotinamide Mononucleotide (nicotinamide mononucleotide)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Hypertension | Phase 4 | Status: UNKNOWN